FDA Grants Fast Track Designation for CS-1103, a First-in-class Small Molecule to Reverse Acute Intoxication from Fentanyl

B CAMBRIDGE, Mass., May 5, 2026 /PRNewswire/ — Clear Scientific Inc., a clinical stage biopharmaceutical company, announced today that the U.S. Food and Drug Administration…
posteditor
posteditor
Articles: 21727

Other News